Gri bio (nasdaq: gri) provides business outlook and highlights upcoming milestones for innovative pipeline of nkt cell modulators

Rapidly advancing c linical pipeline in potential high-value i nflammatory, f ibrotic and a utoimmune d iseases

GRI Ratings Summary

GRI Quant Ranking